Agartala, Tripura, 22nd of January 2025 : With the initiative of International Oncology Cancer Institute a crucial press conference has been organized here in Cancer Care Centre, ILS Hospital, Agartala, Tripura on Wednesday (22nd January, 2025). The Authority of International Oncology Cancer Institute has a comprehensive discussion on institutes.

Amidst the distinguished dignitaries there were Dr. K. Siva Sree , MD , DM Medical Oncology, Dr. Kishalay Baidya, MD Radiation Oncology, Dr. Gourav Dubey, MD Nuclear Medicine, Dr. Goutam Hazarika , CEO ILS Hospital , Dr. Ghulam Abbas Zaidi, Clinical and Business Head North and Northeast, Mr. R. Raman , Unit Head , IOCI -Agartala and many others remained present in the press conference.
In a significant advancement for oncology care in Northeastern India, the International Oncology Cancer Institute (IOCI), India has partnered with ILS Hospitals in Agartala, Tripura, to establish a cutting-edge cancer treatment facility. Founded by Dr. Ashwini Sanger and Dr. Madhu Garg, two visionary U.S.-based oncologists of Indian origin, IOCI was established with a mission to deliver world-class cancer care in India. Over the past 15 years, IOCI has emerged as a national leader in cancer treatment, driven by a patient-centered approach that emphasizes advanced technology, skilled medical teams, and compassionate care.
A Vision for Advanced Cancer Care in Tripura
Dr. Pramod Kumar Sharma, Executive Director of IOCI, shared his enthusiasm about the new partnership, stating, “Our collaboration with ILS Hospital Agartala will bring the latest cancer treatment technology to the people of Tripura, ensuring they receive the best care without leaving their hometown.”
About ILS Hospital Agartala
As a pioneering healthcare institution in Tripura, ILS Hospital Agartala offers a wide range of multidisciplinary services. Through the IOCI-ILS partnership, the new facility will bring specialized cancer treatment and diagnostic services, including:
1. Medical Oncology: Offering advanced systemic therapies such as chemotherapy, targeted therapy, and immunotherapy, led by a team of dedicated oncologists.
2. Radiation Oncology: The facility will soon introduce high-end radiation therapy with state-of-the-art equipment, supported by caring and skilled radiation oncologists.
3. Surgical Oncology: IOCI’s strength in surgical oncology now extends to Agartala, featuring highly experienced surgical oncologists specializing in cancer surgery.
4. Nuclear Medicine: IOCI-ILS Agartala will be the first in Tripura to offer PET-CT scans in a corporate hospital setting, enabling early detection and accurate diagnosis, critical for effective cancer treatment.
5. International Tumor Board: The facility features an interdisciplinary tumor board comprising medical, radiation, and surgical oncologists, as well as pathologists and radiologists, who collaborate to personalize treatment plans. This ensures thorough evaluation, informed decision-making, and effective treatment strategies.
6. Second Opinion Service: IOCI offers an online platform for patients across India and beyond to seek second opinions.
Dr. Madhu Garg emphasizes the value of IOCI’s interdisciplinary approach, saying, “The International Tumor Board, combined with our investment in top medical technologies and highly qualified teams, underscores our commitment to accessible, high-quality cancer care.”
Empowering Patients and Families in Northeastern India
The expansion of IOCI to Agartala represents the institute’s commitment to providing advanced treatment options that are accessible, empowering patients and their families. Dr. Sharma notes, “Our goal is to provide patients with the best care in a respectful and supportive environment.”
A Future of Accessible Oncology Care Nationwide
With the establishment of its 11th facility in Agartala, IOCI continues to strengthen its presence in India, aiming for a future where quality cancer care is accessible to all. Dr. Sanger and Dr. Sharma share a vision for a nationwide network of IOCI hospitals, ensuring that patients from all regions have access to specialized oncology care, cutting-edge treatment, and compassionate support.
More Stories
80 BSF Personnel Donates Blood At RGCIRC To Support Treatment Of Cancer Patients.
Seminar Cum Workshop On Jamatia Customary Law Organized.
Harassment For New Ration Cards.